Post-Operative Pain Management Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Post-Operative Pain Management Market 

5.1. COVID-19 Landscape: Post-Operative Pain Management Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Post-Operative Pain Management Market, By Application

8.1. Post-Operative Pain Management Market, by Application

8.1.1. Surgical Procedures 

8.1.1.1. Market Revenue and Forecast

8.1.2. Chronic Pain Management            

8.1.2.1. Market Revenue and Forecast

8.1.3. Acute Pain Management 

8.1.3.1. Market Revenue and Forecast

8.1.4. Palliative Care 

8.1.4.1. Market Revenue and Forecast

8.1.5. Rehabilitation

8.1.5.1. Market Revenue and Forecast

Chapter 9. Global Post-Operative Pain Management Market, By Type of Pain Relief

9.1. Post-Operative Pain Management Market, by Type of Pain Relief

9.1.1. Pharmacological 

9.1.1.1. Market Revenue and Forecast

9.1.2. Non-Pharmacological 

9.1.2.1. Market Revenue and Forecast

9.1.3. Interventional 

9.1.3.1. Market Revenue and Forecast

9.1.4. Physical Therapy 

9.1.4.1. Market Revenue and Forecast

9.1.5. Psychological Therapy

9.1.5.1. Market Revenue and Forecast

Chapter 10. Global Post-Operative Pain Management Market, By Administration Route 

10.1. Post-Operative Pain Management Market, by Administration Route

10.1.1. Oral 

10.1.1.1. Market Revenue and Forecast

10.1.2. Intravenous 

10.1.2.1. Market Revenue and Forecast

10.1.3. Regional 

10.1.3.1. Market Revenue and Forecast

10.1.4. Topical 

10.1.4.1. Market Revenue and Forecast

10.1.5. Inhalation

10.1.5.1. Market Revenue and Forecast

Chapter 11. Global Post-Operative Pain Management Market, By Duration of Treatment 

11.1. Post-Operative Pain Management Market, by Duration of Treatment

11.1.1. Short-Term 

11.1.1.1. Market Revenue and Forecast

11.1.2. Continuous 

11.1.2.1. Market Revenue and Forecast

11.1.3. Long-Term 

11.1.3.1. Market Revenue and Forecast

11.1.4. Intermittent 

11.1.4.1. Market Revenue and Forecast

11.1.5. Post-Discharge

11.1.5.1. Market Revenue and Forecast

Chapter 12. Global Post-Operative Pain Management Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Application

12.1.2. Market Revenue and Forecast, by Type of Pain Relief

12.1.3. Market Revenue and Forecast, by Administration Route

12.1.4. Market Revenue and Forecast, by Duration of Treatment

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Application

12.1.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.1.5.3. Market Revenue and Forecast, by Administration Route

12.1.5.4. Market Revenue and Forecast, by Duration of Treatment

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Application

12.1.6.2. Market Revenue and Forecast, by Type of Pain Relief

12.1.6.3. Market Revenue and Forecast, by Administration Route

12.1.6.4. Market Revenue and Forecast, by Duration of Treatment

12.2. Europe

12.2.1. Market Revenue and Forecast, by Application

12.2.2. Market Revenue and Forecast, by Type of Pain Relief

12.2.3. Market Revenue and Forecast, by Administration Route

12.2.4. Market Revenue and Forecast, by Duration of Treatment

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Application

12.2.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.2.5.3. Market Revenue and Forecast, by Administration Route

12.2.5.4. Market Revenue and Forecast, by Duration of Treatment

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Application

12.2.6.2. Market Revenue and Forecast, by Type of Pain Relief

12.2.6.3. Market Revenue and Forecast, by Administration Route

12.2.6.4. Market Revenue and Forecast, by Duration of Treatment

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Application

12.2.7.2. Market Revenue and Forecast, by Type of Pain Relief

12.2.7.3. Market Revenue and Forecast, by Administration Route

12.2.7.4. Market Revenue and Forecast, by Duration of Treatment

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Application

12.2.8.2. Market Revenue and Forecast, by Type of Pain Relief

12.2.8.3. Market Revenue and Forecast, by Administration Route

12.2.8.4. Market Revenue and Forecast, by Duration of Treatment

12.3. APAC

12.3.1. Market Revenue and Forecast, by Application

12.3.2. Market Revenue and Forecast, by Type of Pain Relief

12.3.3. Market Revenue and Forecast, by Administration Route

12.3.4. Market Revenue and Forecast, by Duration of Treatment

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Application

12.3.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.3.5.3. Market Revenue and Forecast, by Administration Route

12.3.5.4. Market Revenue and Forecast, by Duration of Treatment

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Application

12.3.6.2. Market Revenue and Forecast, by Type of Pain Relief

12.3.6.3. Market Revenue and Forecast, by Administration Route

12.3.6.4. Market Revenue and Forecast, by Duration of Treatment

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Application

12.3.7.2. Market Revenue and Forecast, by Type of Pain Relief

12.3.7.3. Market Revenue and Forecast, by Administration Route

12.3.7.4. Market Revenue and Forecast, by Duration of Treatment

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Application

12.3.8.2. Market Revenue and Forecast, by Type of Pain Relief

12.3.8.3. Market Revenue and Forecast, by Administration Route

12.3.8.4. Market Revenue and Forecast, by Duration of Treatment

12.4. MEA

12.4.1. Market Revenue and Forecast, by Application

12.4.2. Market Revenue and Forecast, by Type of Pain Relief

12.4.3. Market Revenue and Forecast, by Administration Route

12.4.4. Market Revenue and Forecast, by Duration of Treatment

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Application

12.4.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.4.5.3. Market Revenue and Forecast, by Administration Route

12.4.5.4. Market Revenue and Forecast, by Duration of Treatment

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Application

12.4.6.2. Market Revenue and Forecast, by Type of Pain Relief

12.4.6.3. Market Revenue and Forecast, by Administration Route

12.4.6.4. Market Revenue and Forecast, by Duration of Treatment

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Application

12.4.7.2. Market Revenue and Forecast, by Type of Pain Relief

12.4.7.3. Market Revenue and Forecast, by Administration Route

12.4.7.4. Market Revenue and Forecast, by Duration of Treatment

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Application

12.4.8.2. Market Revenue and Forecast, by Type of Pain Relief

12.4.8.3. Market Revenue and Forecast, by Administration Route

12.4.8.4. Market Revenue and Forecast, by Duration of Treatment

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Application

12.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.5.3. Market Revenue and Forecast, by Administration Route

12.5.4. Market Revenue and Forecast, by Duration of Treatment

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Application

12.5.5.2. Market Revenue and Forecast, by Type of Pain Relief

12.5.5.3. Market Revenue and Forecast, by Administration Route

12.5.5.4. Market Revenue and Forecast, by Duration of Treatment

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Application

12.5.6.2. Market Revenue and Forecast, by Type of Pain Relief

12.5.6.3. Market Revenue and Forecast, by Administration Route

12.5.6.4. Market Revenue and Forecast, by Duration of Treatment

Chapter 13. Company Profiles

13.1. Novartis AG 

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Johnson & Johnson 

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Pfizer Inc. 

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. Merck & Co., Inc. 

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. Bayer AG 

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. GlaxoSmithKline (GSK) plc 

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. AstraZeneca PLC 

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Sanofi S.A.

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. AbbVie Inc. (including Allergan) 

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Teva Pharmaceutical Industries Ltd. 

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms